Beneath the Siberian permafrost, frozen for 4,000 years, lies something that could save millions of modern lives. Scientists ...

"Puts many of the gains of modern medicine at risk." Scientists issue dire warning after discovering why viruses and bacteria ...

In the field of bacteriology, the rapid rise of drug-resistant bacterial infections and the lack of effective antimicrobial ...

Bringing your phone with you everywhere means it's filthier than you think. Keep it free from bacteria and germs with these ...

Aggressive breast cancer can become unresponsive to monoclonal antibody treatment, but targeting tumor-resident bacteria may extend its effectiveness.

UTIs are among the most common infections worldwide, affecting some 15 million women a year. Phenazopyridine, sold under brand names such as Azo and Uristat, is used to treat the pain, burning and ...

Fiber has a ton of GI clout—gastroenterologists regularly praise the nutrient for its ability to keep you regular, nourish ...

Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Roche said on it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and last phase of testing on humans.

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the ...

INRAE scientists have identified seven bacteria involved in the microbiota barrier effect, which prevents pathogenic bacteria ...

A chemistry student at the University of North Florida urges local officials to take action on pharmaceutical pollution.